Outcome of intravenous recombinant tissue plasminogen activator for acute ischemic stroke in patients aged over 80 years.

about

Significances and Outcomes of Mechanical Thrombectomy for Acute Infarction in Very Elderly Patients: A Single Center Experience.Thrombolysis in older adults: To do or not to do, this is the question!

P2860

Q47094877-EBD0575D-1F29-470C-8077-25DC60C65341 Q51671428-BD9D6EF4-BEF2-4447-BFA5-B918652094E0

P2860

Outcome of intravenous recombinant tissue plasminogen activator for acute ischemic stroke in patients aged over 80 years.

Item

http://www.wikidata.org/entity/Q40657034

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Outcome of intravenous recombi ...... n patients aged over 80 years.

@en

type

Item

label

Outcome of intravenous recombi ...... n patients aged over 80 years.

@en

prefLabel

Outcome of intravenous recombi ...... n patients aged over 80 years.

@en

P1476

Outcome of intravenous recombi ...... n patients aged over 80 years.

@en

P2093

Gioia Mione

http://www.w3.org/2001/XMLSchema#string

Hervé Vespignani

http://www.w3.org/2001/XMLSchema#string

Jean-Christophe Lacour

http://www.w3.org/2001/XMLSchema#string

Nathalie Thilly

http://www.w3.org/2001/XMLSchema#string

Sébastien Richard

http://www.w3.org/2001/XMLSchema#string

Xavier Ducrocq

http://www.w3.org/2001/XMLSchema#string

P2860

Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment

The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial

Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials

Risk factors for severe hemorrhagic transformation in ischemic stroke patients treated with recombinant tissue plasminogen activator: a secondary analysis of the European-Australasian Acute Stroke Study (ECASS II)

Thrombolysis in very elderly people: controlled comparison of SITS International Stroke Thrombolysis Registry and Virtual International Stroke Trials Archive

Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke

Tissue plasminogen activator for acute ischemic stroke

Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association

Intravenous thrombolysis with recombinant tissue plasminogen activator for ischemic stroke patients over 80 years old: the Fukuoka Stroke Registry

Stroke in the very old: a systematic review of studies on incidence, outcome, and resource use.

P304

843-849

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/GGI.12565

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-08-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26245693

http://www.w3.org/2001/XMLSchema#string

Outcome of intravenous recombinant tissue plasminogen activator for acute ischemic stroke in patients aged over 80 years.

about

P2860

P2860

Outcome of intravenous recombinant tissue plasminogen activator for acute ischemic stroke in patients aged over 80 years.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698